Insmed To Present at the BofA Securities Health Care Conference 2024

Insmed To Present at the BofA Securities Health Care Conference 2024

BRIDGEWATER, N.J., May 7, 2024/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the BofA Securities Health Care Conference 2024 in Las Vegas, NV, on Tuesday, May 14, 2024at 2:20 p.m. PT(5:20 p.m. ET).

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed
InsmedIncorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed'sfirst commercial product is a first-in-disease therapy approved in the United States, Europe, and Japanto treat a chronic, debilitating lung disease. The Company is progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmedis also advancing an early-stage research engine encompassing a wide range of technologies and modalities, including artificial intelligence-driven protein engineering, gene therapy, and protein manufacturing. Insmedis headquartered in Bridgewater, New Jersey, with additional offices and research locations throughout the United States, Europe, and Japan. Visit www.insmed.comto learn more.

Contact:

Investors:

Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
[email protected]

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
[email protected]

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
[email protected]

SOURCE Insmed Incorporated